Contact Sensitization in Adults With Atopic Dermatitis: A 21‐Year Single‐Center Tertiary Experience
A graphical abstract has been included as supplemental material. ABSTRACT Background Atopic dermatitis is a common chronic inflammatory skin condition. Data on contact sensitization in adults with atopic dermatitis remain limited. Objectives To investigate the prevalence of contact sensitization in adults with and without AD: Patients/Methods A ...
Francesca Caroppo +5 more
wiley +1 more source
ABSTRACT Reliable biomarkers that enable noninvasive, longitudinal assessment of disease activity and therapeutic response remain a major unmet need in inflammatory bowel disease (IBD). While colonic biopsies are the gold standard for evaluating mucosal inflammation, their invasive nature and limited spatial and temporal resolution constrain their ...
Mohamed Hassanein +8 more
wiley +1 more source
Enteric and Controlled-Release Budesonide in IgA Nephropathy: Expanding Access While Refining Evidence. [PDF]
Jhaveri KD, Reich HN.
europepmc +1 more source
Enteric Budesonide Treatment in IgA Nephropathy. [PDF]
Gulati S +8 more
europepmc +1 more source
The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma [PDF]
Bacharier, Leonard B +8 more
core +2 more sources
Generic Controlled-Release Budesonide in IgA Nephropathy - A Single Center Retrospective Study. [PDF]
Bagchi S, Bhowmik D, Agarwal SK.
europepmc +1 more source
A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy. [PDF]
Laxamana TD +3 more
europepmc +1 more source
Use of Janus Kinase Inhibitor Upadacitinib in Microscopic Colitis. [PDF]
Mumm B, Stein DJ.
europepmc +1 more source
Differential association of fluticasone furoate and budesonide with clinically detected COVID-19: a retrospective cohort study. [PDF]
Tsunemi M +7 more
europepmc +1 more source
Efficacy and safety of as-needed albuterol-budesonide versus albuterol in patients with asthma aged 12 to <18 years: design of the randomised, double-blind, parallel-group phase IIIb ACADIA trial. [PDF]
Bacharier LB +7 more
europepmc +1 more source

